Reimbursement & HTA Submissions
We provide end-to-end market access and reimbursement support, including payer value propositions, Canadian HTA submissions, US AMCP dossiers, economic evaluations, budget impact analyses, and tailored evidence packages for public and private payers.
Unlike traditional consulting models, our engagements are delivered exclusively by senior-level experts, working directly with you to define the evidence strategy, address clinical and economic evidence gaps, and guide submission development, quality review, and responses to HTA and payer feedback. This hands-on approach ensures scientifically rigorous, strategically aligned deliverables that effectively communicate your asset’s value and support reimbursement and pricing negotiations.
HTA submissions supported across jurisdictions
Minimum years of experience of each team member
What we deliver
Global value dossiers
Comprehensive, evidence-based dossiers establishing a consistent global value narrative, integrating clinical, economic, and humanistic evidence to be easily adapted to local payer and reimbursement requirements.
Local HTA submissions
Reimbursement dossiers, economic evaluations, and submission materials tailored to local HTA requirements, assessment frameworks, and payer priorities to strengthen your asset’s reimbursement positioning.
Value propositions and messaging
Clear, evidence-based value narratives targeted at key stakeholders which highlights clinical differentiation, unmet needs, economic value, and patient benefits to support market access.
Private payer packages
Tailored dossiers and evidence packages, highlighting clinical and economic value, comparative efficacy, and budget impact to support coverage and formulary decisions.
EU JCA readiness
Early PICO planning, evidence gap assessments, and comparative efficacy evidence preparation aligned with EU HTA requirements to support JCA submissions.
Revision and update cycles
Timely updates to dossiers and supporting evidence to includee new clinical data, pricing changes, or feedback, ensuring alignment with evolving HTA and payer requirements.
How we work
- 01
Strategy and evidence planning
A senior partner works directly with you to define your asset’s value proposition, identify evidence gaps, and establish a market-specific reimbursement strategy.
- 02
Core dossier development
Develop a comprehensive, evidence-based global value story that integrates clinical, economic, and patient-reported outcomes into a cohesive narrative.
- 03
Local adaptation
Translate global evidence into local HTA submissions, reimbursement dossiers, and supporting materials aligned with payer requirements.
- 04
Revisions
Deliver timely, quality-controlled updates and responses to payer and reviewer feedback.
Why Frontier HEOR
Senior partners on every project, not just kickoff.
Direct involvement at every stage, from strategy through final delivery.
Relevance from global to local
A unified, evidence-based value narrative tailored to each market.
Cost-effective for you
Our operations are purposefully lean to remain cost-effective for your needs.